CLEARGATE CAPITAL PARTNERS
CLEARGATE CAPITAL PARTNERS is a Series C+ and buyout fund in the US and Canada writing $10M–$40M checks into healthcare-tech.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech
- Check size
- $10M–$40M
- Invests in
- US-wide, Canada
- Actively investing
- Yes
- Founded
- 2025
- Website
- cleargatecp.com
Thesis
ClearGate Capital Partners is a private equity firm founded in 2025 and headquartered in Chicago, Illinois. They specialize in the lower middle market healthcare sector, targeting founder-owned companies with a clear path for value creation. Their investment thesis centers on identifying and partnering with companies in fragmented, growing healthcare sub-sectors that have profitable operations and potential for technology enhancement. ClearGate employs a hands-on strategy, investing in systems, talent, processes, and go-to-market strategies to accelerate growth and achieve scale. They primarily pursue majority buyouts or recapitalizations (51%-100%) but also consider minority growth capital investments. For platform companies, they look for an EBITDA of $2 to $10 million, with equity investments typically ranging from $10 to $40 million. They have additional capital for add-on investments, with no minimum for these. Geographically, their focus is on the United States and Canada. ClearGate Capital Partners Fund I, LP, established in 2025, is their primary fund, domiciled in Delaware. While AUM is not disclosed, the firm is actively seeking new investments. Interested parties can submit information via a contact form on their website.
Common questions
Does CLEARGATE CAPITAL PARTNERS invest at the Series C+ stage?
Yes. CLEARGATE CAPITAL PARTNERS lists Series C+ and buyout among the stages it invests in.
What check size does CLEARGATE CAPITAL PARTNERS write?
CLEARGATE CAPITAL PARTNERS writes $10M–$40M checks.
Where does CLEARGATE CAPITAL PARTNERS invest?
CLEARGATE CAPITAL PARTNERS invests in the US and Canada.